Effects of chronic methamphetamine on psychomotor and cognitive functions and dopamine signaling in the brain

Panayotis K Thanos1, Ronald Kim1, Foteini Delis2

  • 1Behavioral Neuropharmacology & Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY 14203, USA.

Behavioural Brain Research
|December 21, 2016
PubMed

Insights

Chronic methamphetamine (MA) exposure in rats disrupts behavior and alters the dopamine system. This study modeled long-term MA use, revealing significant impacts on psychomotor function and dopamine transporter levels.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • Animal studies on methamphetamine (MA) typically use acute or short-term exposure models.
  • Human MA addiction involves prolonged, high-dose drug intake, a pattern not well-represented in prior research.
  • Understanding the long-term neurological and behavioral consequences of MA use is crucial for addiction research.

Purpose of the Study:

  • To investigate the effects of chronic methamphetamine exposure on brain and behavior in a rat model.
  • To simulate patterns of MA intake analogous to human addiction.
  • To examine adaptations in the dopaminergic system following prolonged MA treatment.

Main Methods:

  • Rats received daily doses of methamphetamine (4 and 8 mg/kg/day) for 16 weeks.
  • Psychomotor and cognitive functions were assessed using open field and novel object recognition tests.
  • Dopaminergic system adaptations were studied using in vitro and in vivo receptor imaging.

Main Results:

  • Chronic MA treatment disorganized open field activity and impaired exploratory behavior and anxiety-like states.
  • Dopamine transporter levels were downregulated in the striatum.
  • Dopamine terminal integrity in the nucleus accumbens was affected, with reduced dopamine D1 and D2 receptor binding density.

Conclusions:

  • Chronic MA exposure at self-administration-relevant doses significantly alters rat behavior and dopaminergic system function.
  • Findings suggest long-term MA use leads to neuroadaptations impacting motor control, cognition, and reward pathways.
  • Further research into the mechanisms underlying these observed alterations is warranted.

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.1K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.2K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.4K
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.1K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
776
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
505